Donald W. Kufe
ProfessorÂÂ
Pharmacology
Dana-Farber Cancer Institute
United States of America
Biography
Dr. Kufe received his MD in 1970 from the University of Rochester School of Medicine. After a clinical fellowship in medical oncology at Dana-Farber Cancer Institute, he joined the staff in 1979. He has served as chief of the Division of Cancer Pharmacology, deputy director of the Dana-Farber Cancer Center, director of the Harvard Phase I Oncology Group and leader of the Experimental Therapeutics Program. He is an editor of the textbook "Cancer Medicine."
Research Interest
Pharmacology
Publications
-
Rajabi H, Kufe D (2017) MUC1-C Oncoprotein Integrates a Program of EMT, Epigenetic Reprogramming and Immune Evasion in Human Carcinomas. Biochim Biophys Acta 1 :117-122.
-
Shukla V, Dalela M, Vij M, Weichselbaum R, Kharbanda S et al (2017) Systemic delivery of the tumor necrosis factor gene to tumors by a novel dual DNA-nanocomplex in a nanoparticle system. Nanomedicine 5 :1833-1839.
-
Rajabi H, Hiraki M, Tagde A, Alam M, Bouillez A et al (2017) MUC1-C activates EZH2 expression and function in human cancer cells. Sci Rep 1 :7481.
